Mitchell Krucoff

Mitchell Krucoff

Dr. Mitchell W. Krucoff is a native of Washington D.C. He graduated Yale University in 1976 Magna Cum Laude with a degree in religious studies and philosophy. He earned his M.D. from George Washington University in 1980, where he was elected to the Alpha Omega Alpha Honor Society. His first clinical research experience was with Professor Attilio Maseri at the Hammersmith Hospital in London in 1983, following which he trained in cardiology at Georgetown University where he was Chief Fellow in Cardiology and remained on staff as an interventional cardiologist, Co-Director of the Cardiac Catheterization Laboratory and Medical Director of the Cardiovascular Intensive Care Unit.

In 1988 Dr. Krucoff joined the cardiology faculty at Duke University Medical Center where he remains to this date. He is currently fully tenured as a Professor of Medicine/Cardiology, member of the Duke Senior Interventional Cardiology Staff and Director of the Cardiovascular Laboratories at the Durham VA Medical Center. In his research activities he is the Director of the Cardiovascular Devices Unit at the Duke Clinical Research Institute and a member of the Circulatory Devices Panel, Center for Devices and Radiological Health at FDA. Dr. Krucoff is the founder and Director of the Ischemia Monitoring Laboratory and eECG Core Laboratory, the largest academic electronic ECG Core Laboratory in the world. In exploring new healing paradigms complementary to modern high tech medical practices Dr. Krucoff has served on the Board of Directors of the Sri Satya Sai Institute of Higher Medical Sciences in Puttaparthi, India since 1990 and is currently the Director of the MANTRA Study Project at the DCRI. He was Editor In Chief of Alternative Therapies in Health and Medicine and is currently Senior Editor of the peer review Journal of Alternative and Complementary Medicine. Areas of clinical and research activities and publications include strategies of elective and acute coronary revascularization, high risk revascularization, diagnosis and interventions in acute coronary syndromes, and complementary therapies and spirituality applications in high tech cardiovascular care.